Related Experiment Video
Updated: Mar 17, 2026
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
When is Transplantation with a "Marginal Kidney" Justifiable?
Alireza Heidary Rouchi1, Mitra Mahdavi-Mazdeh1
1Iranian Tissue Bank and Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
The ability of kidney transplantation to improve quality of life has made this therapeutic modality the treatment of choice among renal replacement therapies; however, the continuing organ shortage has forced the use of marginal kidneys as a supplementary source of allografts. It has been repeatedly suggested that failed kidney transplant recipients have greater morbidity and mortality compared with dialysis patients with no renal transplant history. Achieving an optimal balance between the advantages of kidney transplant and disadvantages of allografts with marginal quality is a topic of controversy in transplant medicine. The major and potentially life-threatening complications of immunosuppressive therapies and shorter lifespan following graft failure necessitate a reappraisal of kidney transplant programs from expanded-criteria deceased donors, which can neither necessarily give dialysis patients a better quality of life nor a significant survival benefit, especially in settings with additional diminished graft survival due to HLA-mismatch. It should be offered just to those with short life expectancy and with HLA-matching. The last item is very important in countries without mandatory HLA-matching protocols for kidney transplantation programs.
Insights
Kidney transplants improve quality of life, but marginal organs and immunosuppression pose risks. Consider transplants from expanded criteria donors only for patients with short life expectancy and HLA-matching.
Area of Science:
- Nephrology
- Transplant Medicine
- Immunology
Background:
- Kidney transplantation is the preferred renal replacement therapy due to improved quality of life.
- Organ shortages necessitate the use of marginal kidneys, raising concerns about recipient outcomes.
- Failed transplant recipients may experience higher morbidity and mortality than dialysis patients.
Purpose of the Study:
- To evaluate the balance between kidney transplant benefits and risks associated with marginal allografts.
- To reappraise kidney transplant programs utilizing expanded-criteria deceased donors.
- To identify optimal patient selection criteria for marginal kidney transplants.
Main Methods:
- Comparative analysis of outcomes between kidney transplant recipients and dialysis patients.
- Review of complications associated with immunosuppressive therapies.
- Assessment of graft survival factors, including HLA-matching.
Main Results:
- Marginal allografts and immunosuppression complications can negate quality of life benefits.
- Expanded-criteria donor transplants may not improve survival compared to dialysis, especially with HLA-mismatch.
- HLA-matching is crucial for improving graft survival in kidney transplantation.
Conclusions:
- Kidney transplantation from expanded-criteria donors requires careful patient selection.
- Transplants should be reserved for individuals with short life expectancy and confirmed HLA-matching.
- Mandatory HLA-matching protocols are essential for optimizing outcomes in kidney transplant programs.
Related Concept Videos
01:28Kidney Transplant I: Introduction
01:26Kidney Transplant II: Surgical Procedure
01:16Kidney Transplant III: Nursing Management